These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34451975)

  • 1. A Single-Cycle Influenza A Virus-Based SARS-CoV-2 Vaccine Elicits Potent Immune Responses in a Mouse Model.
    Koonpaew S; Kaewborisuth C; Srisutthisamphan K; Wanitchang A; Thaweerattanasinp T; Saenboonrueng J; Poonsuk S; Jengarn J; Viriyakitkosol R; Kramyu J; Jongkaewwattana A
    Vaccines (Basel); 2021 Aug; 9(8):. PubMed ID: 34451975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuated influenza virions expressing the SARS-CoV-2 receptor-binding domain induce neutralizing antibodies in mice.
    Loes AN; Gentles LE; Greaney AJ; Crawford KHD; Bloom JD
    bioRxiv; 2020 Sep; ():. PubMed ID: 32817935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel DNA Vaccine Against SARS-CoV-2 Encoding a Chimeric Protein of Its Receptor-Binding Domain (RBD) Fused to the Amino-Terminal Region of Hepatitis B Virus preS1 With a W4P Mutation.
    Jeong H; Choi YM; Seo H; Kim BJ
    Front Immunol; 2021; 12():637654. PubMed ID: 33732258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A live attenuated virus-based intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2.
    Chen J; Wang P; Yuan L; Zhang L; Zhang L; Zhao H; Chen C; Wang X; Han J; Chen Y; Jia J; Lu Z; Hong J; Lu Z; Wang Q; Chen R; Qi R; Ma J; Zhou M; Yu H; Zhuang C; Liu X; Han Q; Wang G; Su Y; Yuan Q; Cheng T; Wu T; Ye X; Zhang T; Li C; Zhang J; Zhu H; Chen Y; Chen H; Xia N
    Sci Bull (Beijing); 2022 Jul; 67(13):1372-1387. PubMed ID: 35637645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of spike receptor-binding domain nanoparticle as a vaccine candidate against SARS-CoV-2 infection in ferrets.
    Kim YI; Kim D; Yu KM; Seo HD; Lee SA; Casel MAB; Jang SG; Kim S; Jung W; Lai CJ; Choi YK; Jung JU
    bioRxiv; 2021 Jan; ():. PubMed ID: 33532767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains.
    Ryder AB; Nachbagauer R; Buonocore L; Palese P; Krammer F; Rose JK
    J Virol; 2015 Dec; 90(5):2544-50. PubMed ID: 26676789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Engineered Receptor-Binding Domain Improves the Immunogenicity of Multivalent SARS-CoV-2 Vaccines.
    Guo Y; He W; Mou H; Zhang L; Chang J; Peng S; Ojha A; Tavora R; Parcells MS; Luo G; Li W; Zhong G; Choe H; Farzan M; Quinlan BD
    mBio; 2021 May; 12(3):. PubMed ID: 33975938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrogel-based slow release of a receptor-binding domain subunit vaccine elicits neutralizing antibody responses against SARS-CoV-2.
    Gale EC; Powell AE; Roth GA; Meany EL; Yan J; Ou BS; Grosskopf AK; Adamska J; Picece VCTM; Dâ Aquino AI; Pulendran B; Kim PS; Appel EA
    bioRxiv; 2021 Aug; ():. PubMed ID: 33821276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants.
    Tai W; Wang Y; Fett CA; Zhao G; Li F; Perlman S; Jiang S; Zhou Y; Du L
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Immunomodulatory Evaluation of the Receptor Binding Domain of the SARS-CoV-2 Spike Protein; a Potential Vaccine Candidate Which Imparts Potent Humoral and Th1 Type Immune Response in a Mouse Model.
    Shrivastava T; Singh B; Rizvi ZA; Verma R; Goswami S; Vishwakarma P; Jakhar K; Sonar S; Mani S; Bhattacharyya S; Awasthi A; Surjit M
    Front Immunol; 2021; 12():641447. PubMed ID: 34108961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid Development of SARS-CoV-2 Spike Protein Receptor-Binding Domain Self-Assembled Nanoparticle Vaccine Candidates.
    Kang YF; Sun C; Zhuang Z; Yuan RY; Zheng Q; Li JP; Zhou PP; Chen XC; Liu Z; Zhang X; Yu XH; Kong XW; Zhu QY; Zhong Q; Xu M; Zhong NS; Zeng YX; Feng GK; Ke C; Zhao JC; Zeng MS
    ACS Nano; 2021 Feb; 15(2):2738-2752. PubMed ID: 33464829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity.
    Yang J; Wang W; Chen Z; Lu S; Yang F; Bi Z; Bao L; Mo F; Li X; Huang Y; Hong W; Yang Y; Zhao Y; Ye F; Lin S; Deng W; Chen H; Lei H; Zhang Z; Luo M; Gao H; Zheng Y; Gong Y; Jiang X; Xu Y; Lv Q; Li D; Wang M; Li F; Wang S; Wang G; Yu P; Qu Y; Yang L; Deng H; Tong A; Li J; Wang Z; Yang J; Shen G; Zhao Z; Li Y; Luo J; Liu H; Yu W; Yang M; Xu J; Wang J; Li H; Wang H; Kuang D; Lin P; Hu Z; Guo W; Cheng W; He Y; Song X; Chen C; Xue Z; Yao S; Chen L; Ma X; Chen S; Gou M; Huang W; Wang Y; Fan C; Tian Z; Shi M; Wang FS; Dai L; Wu M; Li G; Wang G; Peng Y; Qian Z; Huang C; Lau JY; Yang Z; Wei Y; Cen X; Peng X; Qin C; Zhang K; Lu G; Wei X
    Nature; 2020 Oct; 586(7830):572-577. PubMed ID: 32726802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal Administration of RBD Nanoparticles Confers Induction of Mucosal and Systemic Immunity against SARS-CoV-2.
    Jearanaiwitayakul T; Seesen M; Chawengkirttikul R; Limthongkul J; Apichirapokey S; Sapsutthipas S; Phumiamorn S; Sunintaboon P; Ubol S
    Vaccines (Basel); 2021 Jul; 9(7):. PubMed ID: 34358183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent RBD-specific neutralizing rabbit monoclonal antibodies recognize emerging SARS-CoV-2 variants elicited by DNA prime-protein boost vaccination.
    Chen Y; Zhu L; Huang W; Tong X; Wu H; Tao Y; Tong B; Huang H; Chen J; Zhao X; Lou Y; Wu C
    Emerg Microbes Infect; 2021 Dec; 10(1):1390-1403. PubMed ID: 34120577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "A recombinant protein SARS-CoV-2 candidate vaccine elicits high-titer neutralizing antibodies in macaques.".
    Baisa G; Rancour D; Mansfield K; Burns M; Martin L; Cunha D; Fischer J; Muecksch F; Hatziioannou T; Bieniasz PD; Schomburg F; Luke K
    bioRxiv; 2020 Dec; ():. PubMed ID: 33398285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chimeric influenza virus hemagglutinin proteins containing large domains of the Bacillus anthracis protective antigen: protein characterization, incorporation into infectious influenza viruses, and antigenicity.
    Li ZN; Mueller SN; Ye L; Bu Z; Yang C; Ahmed R; Steinhauer DA
    J Virol; 2005 Aug; 79(15):10003-12. PubMed ID: 16014960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid Transient Expression of Receptor-Binding Domain of SARS-CoV-2 and the Conserved M2e Peptide of Influenza A Virus Linked to Flagellin in
    Mardanova ES; Kotlyarov RY; Ravin NV
    Plants (Basel); 2022 Dec; 11(24):. PubMed ID: 36559537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production and Purification of LTB-RBD: A Potential Antigen for Mucosal Vaccine Development against SARS-CoV-2.
    Solis-Andrade KI; Gonzalez-Ortega O; Govea-Alonso DO; Comas-Garcia M; Rosales-Mendoza S
    Vaccines (Basel); 2022 Oct; 10(10):. PubMed ID: 36298624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influenza Virus-like Particle-Based Hybrid Vaccine Containing RBD Induces Immunity against Influenza and SARS-CoV-2 Viruses.
    Bommireddy R; Stone S; Bhatnagar N; Kumari P; Munoz LE; Oh J; Kim KH; Berry JTL; Jacobsen KM; Jaafar L; Naing SH; Blackerby AN; Gaag TV; Wright CN; Lai L; Pack CD; Ramachandiran S; Suthar MS; Kang SM; Kumar M; Reddy SJC; Selvaraj P
    Vaccines (Basel); 2022 Jun; 10(6):. PubMed ID: 35746552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tailoring subunit vaccine immunity with adjuvant combinations and delivery routes using the Middle East respiratory coronavirus (MERS-CoV) receptor-binding domain as an antigen.
    Lan J; Deng Y; Chen H; Lu G; Wang W; Guo X; Lu Z; Gao GF; Tan W
    PLoS One; 2014; 9(11):e112602. PubMed ID: 25405618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.